
Biocon Q2 FY26 revenue rises 20% to ₹4,296 crore, driven by biosimilars growth
Biocon Ltd reported Q2 FY26 revenue of ₹4,296 crore, up nearly 20% YoY, led by strong biosimilars performance and improving margins across global markets.

Biocon Ltd reported Q2 FY26 revenue of ₹4,296 crore, up nearly 20% YoY, led by strong biosimilars performance and improving margins across global markets.

Record date for the rights issue has been fixed as November 17, 2025. Those shareholders who have shares of Adani Enterprises as of Friday, November…

Pine Labs’ ₹3,900 crore IPO was subscribed 2.5 times, driven by strong institutional interest but tepid retail demand amid valuation and profitability concerns.

Pearl Global Industries reported a 25.5% YoY rise in Q2 FY26 profit to ₹73.3 crore, supported by strong growth in Vietnam and Indonesia. The company…

JB Pharma reported a 19% net profit rise to ₹207.8 crore, driven by strong domestic sales of Cilacar, Metrogyl, Nicardia, Sporlac, and Razel, with international…

JSW Steel is exploring the sale of up to 50% in Bhushan Power & Steel, with Japan’s JFE Steel emerging as the frontrunner for the…

EIH Ltd, parent of Oberoi Group, is the third largest hotel stock by market capitalisation in India.

Max Financial Services reported a 96% YoY drop in Q2 profit to ₹4.1 crore, hit by weak life insurance performance. Shares of the company ended…

Landmark Cars posted a turnaround in Q2FY26 with a net profit of ₹1.18 crore and a 34% jump in revenue. The company expects stronger margins…

The company reported ₹814.9 crore in revenue from operations, up 15.9% over last year and 24.9% over the previous quarter. The Q2 EBITDA margin improved by…